Other
Are artificial wombs the future?
- The EU-funded team of European experts intends to develop the world's first clinically approved artificial womb to assist premature infants, specifically aiming to support babies around 28 weeks gestation by providing a liquid-filled polymer environment that facilitates lung development more effectively than standard incubators.
- Development plans include the use of computational modeling to predict cardiovascular system behavior and silicone rubber mannequins to simulate the transfer process, with the goal of postponing animal experiments while resolving challenges related to blood coagulation and safely transferring a fetus from the mother via a liquid tunnel.
- The expected clinical trajectory involves a baby remaining in the artificial womb for approximately four weeks receiving oxygen and nutrients through an artificial placenta, with a critical window of only a few minutes for umbilical cord reattachment to prevent brain damage from oxygen lack.
- Market expectations indicate the technology will not be affordable initially and a decade-long timeline is projected before global rollout, though the team explicitly restricts the technology's use to supporting existing pregnancies and rules out growing babies entirely from conception to birth or for gestational stages earlier than 28 weeks.